Condition
Metastatic Tumor clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Metastatic Tumor clinical trials that are recruiting, at sites in 6 countries (most in United States (3), Canada (1), Switzerland (1)). By phase: Phase 1 (3), Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 6Countries
Newest Metastatic Tumor clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| 5-Azacitidine with PD-1/PD-L1 Inhibitor in PD-1/PD-L1 Refractory Tumors | Phase 1 | Iowa City, Iowa | Recruiting | Feb 11, 2026 |
| Evaluating NKT3964 for Adults with Advanced Solid Tumors | Phase 1 | Little Rock, Arkansas and 20 other locations | Recruiting | Sep 19, 2024 |
| Evaluating treatment outcomes for hormone-sensitive metastatic prostate cancer | — | Orbassano, Torino and 2 other locations | Recruiting | Jun 25, 2024 |
| Radiation treatment for high-risk spine cancer patients | Phase 2 | Stony Brook, New York | Recruiting | Dec 11, 2023 |
| Stereotactic Ablative Radiotherapy for Patients with Oligometastases and a Primary Tumor | Phase 3 | Prince George, British Columbia and 4 other locations | Recruiting | Feb 8, 2023 |
| CD70-targeted CAR-T therapy for advanced solid tumors | Phase 1 | Hangzhou, Zhejiang | Recruiting | Aug 26, 2022 |
All recruiting trials (6)
-
5-Azacitidine with PD-1/PD-L1 Inhibitor in PD-1/PD-L1 Refractory Tumors
This phase I study tests different doses of 5-azacitidine combined with a PD-1/PD-L1 blocker to see if the combo can help patients whose tumors no longer respond to PD-1/PD-L1 therapy.
-
Evaluating NKT3964 for Adults with Advanced Solid Tumors
This study is testing a new drug called NKT3964 to see if it can safely help adults with advanced solid tumors, like ovarian or triple-negative breast cancer, after other treatments have failed.
-
Evaluating treatment outcomes for hormone-sensitive metastatic prostate cancer
This study looks at how well different treatments work for men with hormone-sensitive metastatic prostate cancer who have just started hormone therapy.
-
Radiation treatment for high-risk spine cancer patients
This study is testing a new type of radiation treatment for patients with cancer that has spread to the spine to see if it can help manage their condition without needing major surgery.
-
Stereotactic Ablative Radiotherapy for Patients with Oligometastases and a Primary Tumor
This study is testing if adding a special type of targeted radiation therapy to standard treatment can help people with a primary tumor and a few metastases feel better and live longer.
-
CD70-targeted CAR-T therapy for advanced solid tumors
This study is testing a new type of CAR-T therapy that targets CD70 to see if it can safely help people with advanced solid tumors.
Related topics
Quick answers
How many Metastatic Tumor clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (3 trials), Canada (1 trial), Switzerland (1 trial), South Korea (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.